Medical review pending · noindex

Procedure comparison

Aquablation vs TURP: Robotic Waterjet or Resection?

Aquablation uses image-guided robotic waterjet tissue removal; TURP uses electrosurgical resection. Both are tissue-removing procedures, not equivalent versions of the same operation. The practical choice depends on prostate anatomy, anesthesia, bleeding-control plan, ejaculation priorities, tissue handling, recovery logistics, evidence follow-up and whether the hospital and surgeon routinely perform the technique.

Decision-support boundary: This draft does not diagnose obstruction, select a procedure, or tell anyone to stop medication. Inability to urinate, fever with urinary symptoms, heavy bleeding, severe pain or rapidly worsening symptoms need prompt medical attention.

Direct answer

The better option is the one that fits measured anatomy and the outcomes you prioritize after contraindications, clinician experience, evidence limits and the complete recovery pathway are reviewed. Neither side of this comparison is universally superior.

Start by confirming why symptoms are occurring. Lower urinary tract symptoms can reflect prostatic obstruction, bladder dysfunction, infection, urethral narrowing, medicines, neurologic conditions or more than one factor. NIDDK notes that tests help clinicians diagnose urinary problems and determine treatment options. A procedure comparison becomes useful only after that diagnostic work is connected to the actual choice.

Aquablation vs TURP: decision matrix

Decision factorAquablationTURP
How tissue is removedA surgeon maps the treatment and a robotically controlled high-velocity waterjet removes selected tissue.A surgeon directly resects tissue in chips using an electrosurgical loop.
Imaging and planningReal-time imaging and a planned contour are integral to the procedure.Endoscopic visualization and surgeon-controlled resection define the cavity.
Bleeding controlHemostasis is a distinct step and should be discussed in the local protocol.Electrosurgical technique is used during resection; bleeding risk remains individualized.
Sexual prioritiesTrial data include ejaculatory outcomes, but individual preservation cannot be promised.Ejaculatory change is an established consent topic; compare outcome definitions carefully.
Evidence maturityRandomized comparative evidence exists, with technique and system evolution to consider.Long clinical history and broad familiarity provide a different evidence context.
AccessRequires the system, trained team and institutional pathway.Generally more widely available, but local technique and experience vary.

This table describes decision dimensions, not a personalized recommendation. Device labeling, guideline language, techniques and local pathways can change; verify current details with the treating clinicians.

When the first pathway may enter the discussion

  • Your anatomy fits the current system and evidence population.
  • Ejaculation-related tradeoffs are a high priority in shared decision-making.
  • An experienced center can explain its bleeding-control and follow-up pathway.

When the second pathway or another route may fit

  • TURP is a strong anatomical fit and readily available.
  • You value a long-established technique with local operator experience.
  • The planned resection and risk profile are clear to you.

Do not compare unlike outcomes

Ask whether a study reports symptom score, peak urinary flow, quality of life, catheter independence, adverse events or repeat treatment. Those outcomes are related but not interchangeable. Also check the starting severity, prostate anatomy, exclusions, follow-up duration and how many participants supplied data at the reported time point. A five-year result from a selected trial population is not a guarantee for an individual.

For sexual outcomes, separate erection, ejaculation, orgasm, libido and fertility. A statement that erectile function was stable does not establish that antegrade ejaculation was preserved. For recovery, separate time to discharge, catheter removal, return to work, urinary irritation and full activity. Marketing phrases that collapse these outcomes can make a procedure appear more certain than the evidence supports.

Questions to take to the consultation

  1. Does my anatomy resemble patients in the comparative evidence?
  2. Which Aquablation system and protocol does this hospital use?
  3. How is bleeding controlled after the waterjet step?
  4. What are your transfusion and return-to-operating-room rates?
  5. How do you define ejaculatory preservation?
  6. Will tissue be sent to pathology?
  7. What is the catheter and discharge pathway?
  8. What happens if symptoms persist?
Useful request: Ask the clinician to mark which facts are known from your testing, which are estimates from published evidence, and which depend on the center’s own protocol. Request written catheter, medication and after-hours instructions before scheduling.

Evidence and review status

This page uses authoritative patient guidance, a professional guideline and procedure-specific clinical evidence where available. It deliberately avoids unsourced prices, universal recovery times and promises of preserved sexual function. It remains excluded from the XML sitemap until a qualified medical reviewer checks every material claim, current device labeling and the final comparison language.

Sources accessed September 21, 2026. A source link does not mean the source endorses UriSmooth or this page.

Frequently asked questions

1. What should I know about robotic waterjet treatment?

Robotic waterjet treatment is one decision dimension, not a verdict for Aquablation or TURP. Ask the clinician to connect it to your documented obstruction, baseline symptoms, health history and the center’s technique, then identify what remains uncertain after current evidence is applied.

2. What should I know about TURP resection?

TURP resection is one decision dimension, not a verdict for Aquablation or TURP. Ask the clinician to connect it to your documented obstruction, baseline symptoms, health history and the center’s technique, then identify what remains uncertain after current evidence is applied.

3. What should I know about prostate size?

Prostate size can change whether either side of this comparison is technically suitable. Have the clinician connect current imaging and test findings to Aquablation, TURP and any excluded option; do not infer eligibility from symptoms or an old size estimate alone.

4. What should I know about bleeding control?

Bleeding control requires a coordinated plan, not self-directed medication changes. Ask the procedural clinician and prescribing clinician how Aquablation and TURP differ for your clotting risk, technique, monitoring and restart instructions.

5. What should I know about catheter duration?

Catheter duration is part of the practical Aquablation versus TURP decision. Ask whether a catheter is planned, what triggers removal, where a voiding trial occurs and who responds if emptying fails. Your baseline residual urine and bladder function can matter more than a generic average.

6. What should I know about hospital stay?

Hospital stay depends on the exact pathway used for Aquablation or TURP. Request written instructions covering transport, discharge, urinary symptoms, activity limits, after-hours contact and the conditions that delay return to normal activity.

7. What should I know about ejaculation?

Ejaculation must be defined before comparing Aquablation with TURP. Ask what was measured at baseline, whether ejaculation and erection were reported separately, how many patients supplied follow-up, and why your medicines or health conditions may produce a different outcome.

8. What should I know about erections?

Erections must be defined before comparing Aquablation with TURP. Ask what was measured at baseline, whether ejaculation and erection were reported separately, how many patients supplied follow-up, and why your medicines or health conditions may produce a different outcome.

9. What should I know about pathology?

Pathology changes what remains after treatment and what information is available later. Ask whether Aquablation or TURP leaves an implant, supplies tissue for examination, or alters future imaging and procedural choices.

10. What should I know about retreatment?

Retreatment should be compared at the same follow-up interval with the same definition. For Aquablation and TURP, ask for the number treated, number assessed later, repeat-procedure criteria and the treating center’s own follow-up process.

11. What should I know about device availability?

Device availability changes what remains after treatment and what information is available later. Ask whether Aquablation or TURP leaves an implant, supplies tissue for examination, or alters future imaging and procedural choices.

12. What should I know about operator experience?

Operator experience can materially affect the real-world choice between Aquablation and TURP. Ask about training, recent case volume, complication tracking, rescue plans and whether another local center offers stronger expertise for your anatomy.

Next decision

Return to the BPH procedure decision hub, compare medication versus a procedure, or build a recovery and catheter plan. UriSmooth is not presented as a substitute for evaluation or a procedure.